VENOUS THROMBOEMBOLIC DISEASE
Clinical trials for VENOUS THROMBOEMBOLIC DISEASE explained in plain language.
Never miss a new study
Get alerted when new VENOUS THROMBOEMBOLIC DISEASE trials appear
Sign up with your email to follow new studies for VENOUS THROMBOEMBOLIC DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Blood clot patients on heart drugs: which combo is safest?
Disease control Recruiting nowThis study looks at people who have a blood clot (venous thromboembolism) and also take antiplatelet drugs for heart or stroke prevention. The goal is to find the best combination of blood thinners that prevents more clots without causing dangerous bleeding. About 1,400 participa…
Matched conditions: VENOUS THROMBOEMBOLIC DISEASE
Phase: PHASE3 • Sponsor: Centre Hospitalier Universitaire de Saint Etienne • Aim: Disease control
Last updated May 17, 2026 02:18 UTC
-
Could a simple pill replace daily shots for blood clot prevention in cancer?
Disease control Recruiting nowThis study looks at whether lower doses of two common blood thinner pills (apixaban and rivaroxaban) work as well as standard daily injections to prevent dangerous blood clots in people with blood cancers like lymphoma, leukemia, and multiple myeloma. About 100 participants will …
Matched conditions: VENOUS THROMBOEMBOLIC DISEASE
Phase: NA • Sponsor: Medical University of Gdansk • Aim: Disease control
Last updated May 04, 2026 16:20 UTC
-
Blood thinner breakthrough could slash clot risk in rare anemia
Prevention Recruiting nowThis study tests whether taking a blood thinner for 12 weeks can prevent dangerous blood clots in people with autoimmune hemolytic anemia (AIHA), a rare disease where the immune system destroys red blood cells. About 72 adults with newly diagnosed or relapsed AIHA will be randoml…
Matched conditions: VENOUS THROMBOEMBOLIC DISEASE
Phase: PHASE2 • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Prevention
Last updated May 15, 2026 11:57 UTC
-
Massive chinese trial aims to stop silent killer clots in hospitals
Knowledge-focused Recruiting nowThis study tests whether a hospital-wide quality improvement program can increase the use of blood clot prevention methods (like blood thinners or compression devices) in hospitalized patients. About 5,800 adults across multiple hospitals in China will take part. The goal is to s…
Matched conditions: VENOUS THROMBOEMBOLIC DISEASE
Phase: NA • Sponsor: China-Japan Friendship Hospital • Aim: Knowledge-focused
Last updated May 17, 2026 02:19 UTC